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It has long been known that acute rheumatic fever and rheumatic heart disease
are triggered by antecedent infections due to groupA streptococci. Nevertheless,
the molecular mechanisms of the pathogenesis of the cardiac disease have
remained a mystery. A number of studies have shown that group A streptococci
contain antigens that crossreact with human myocardium (1-8), including the
surface M protein of some serotypes (9-14). In addition, sera from patients with
acute rheumatic fever contain heart-crossreactive antibodies (1, 4, 8) that react
with streptococcal antigens (1, 8). However, heart-crossreactive antibodies are
also present in the sera of patients after uncomplicated streptococcal pharyngitis
(4). Thus, the role of the tissue-crossreactive antibodies in the pathogenesis of
rheumatic carditis remains unclear.
We have previously shown that normal human adult and neonatal lymphocytes,
when cultured in the presence of highly purified peptic extracts of M protein
(pep M) undergo brisk blastogenic responses, as measured by [sH]thymidine
uptake (15). The proliferative responses were T cell specific, dependent on
adherent cells, and did not correlate with serum antibody titers (15). Lympho-
cytes from nonimmune laboratory animals were unresponsive to any of the M
proteins, but after immunization with one serotype of M protein, T cell blasto-
genesis was observed in response to all serotypes of M protein tested . Moreover,
in a later study we showed that lymphocytes from rabbits immunized with a
synthetic dodecapeptide of type 24 M protein were primed to respond to
subsequent in vitro challenge with type 24 and type 5 M proteins (16).
Because the T lymphocyte responses to M proteins appeared to lack the
serotype-specificity associated with humoral immunity to these antigens, and
because all human adult and neonatal T cells tested underwent blastogenesis in
response to purified M proteins, we undertook studies to determine the effector
function of M protein-stimulated T lymphocytes. In the present study we show
that highly purified peptic extracts of types 5, 6, and 19 streptococcal M proteins
(pep M) induce human cytotoxic T lymphocytes (CTL) against several different
human target cells, including cultured myocardial cells, whereas minimal cyto-
toxicity was observed against target cells of animal origin. We show in addition
that the M protein-stimulated human CTL are CD3' and are distinct from
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classic natural killer (NK) cells, and that a subset of these cells has specificity for
M protein-crossreactive antigens on the surface of myocardial cells.
Materials and Methods
Extraction and Purification of M Proteins.
￿
M protein was purified from limited peptic
digests of types 5, 6, 19, and 24 streptococci as previously described (17). The purified
proteins (pep M) were judged to be homogeneous by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis(17).
Purtfcation ofLymphocytes.
￿
Mononuclear cells(MNC)' were isolated by Ficoll-Hypaque
gradient centrifugation (18) from heparinized (100 U/ml) whole blood obtained from
normal adults. Cells were washed three times, counted, and resuspended in RPMI-1640
(Gibco, Grand Island, NY) supplemented with penicillin (100 U/ml), streptomycin (100
Ag/ml), L-glutamine (2 mM), and Hepes buffer (25 mM). Viability was assessed by trypan
blue exclusion. Mononuclear cells were adherent cell-depleted by incubating overnight
in 150-mm petri dishes (1013, Falcon Labware, Oxnard, CA) in complete medium with
10% FCS (Hyclone Laboratories, Logan, UT) at 37°C.
Mononuclear cells were furtherpurified according to cell surface phenotype on a flow
cytometer (Epics 753 Coulter Electronics, Hialeah, FL) using the monoclonal antibodies
anti-CD3, anti-CD4, and anti-CD8 (Coulter Electronics). Nonadherent cells were washed
once in RPMI-1640, incubated with the monoclonal antibodies according to themanufac-
turer's instructions, and then sorted using sterile reagents. Purity of the sorted cell
populations ranged from 98.9 to 99.6%.
Target Cells.
￿
The following cell lines were obtained from theAmerican Type Culture
Collection (Rockville, MD): Girardi heart cells (CCL 27), Chang liver cells (CCL 13), and
BHK-21 (C-13) (CCL 10). Human, rat, and mouse fibroblasts were obtained from primary
explants of skin by methods previously reported (19). Cellswere cultured in MEM (Gibco)
supplemented with penicillin, streptomycin, L-glutamine, Hepes buffer in the concentra-
tions stated above, and 10% FCS. K562 cells were kindly donated by Dr. Chris Bever of
this institution, and were cultured in RPMI supplemented as above.
Lymphocyte Cultures.
￿
2 X 106 MNC/ml were cultured in the presence ofpepMproteins
at a concentration of 5 ug/ml unless otherwise stated in complete RPMI with 10% FCS
in 17 X 100-mm tubes (2057; Falcon Labware) at 37°C in an atmosphere of 5% C02
(15). In some experiments cells were cultured in the presence of either 10 U/ml IL-2
(Collaborative Research, Inc., Bedford, MA) 10 ug/ml Con A (Sigma Chemcial Co., St.
Louis, MO)or pep M proteinplus 250 U/ml rabbit anti-human IFN-,y (Ventrex, Portland,
ME). Control MNC were cultured in complete medium alone. CD3+, CD4+, and CD8+
cells (106 cells/ml) were cultured in complete medium plus 10% FCS, to which 5 X 105
cells/ml irradiated (3,000 rad) autologous MNC had been added as antigen-presenting
cells.
Cytotoxicity Assays.
￿
Target cells grown in monolayers were plated into 96-well flat-
bottom culture dishes (3596; Costar, Cambridge, MA) at 10 cells/well 16 h before
performing cytotoxicity assays. Cells were labeled with "Cr by aspirating the culture
medium and adding 0.1 ml Ca"/Me'-free HBSS (Gibco) containing 2% FCS and 2 /.Ci
Nay'Cr (spact 500mCi/mg; NewEngland Nuclear, Boston,MA). Thecellswere incubated
for 3 h at 37'C, the supernatants were aspirated, and the cells were washed twice with
complete medium. 106 K562 cells were labeled in 1 ml RPMI containing 10% FCS and
100 ACi 5'Cr for 3 h at 37 °C, washed twice in complete medium, andplated into round-
bottom 96-well culture plates (3799; Costar) at 104 cells/well.
Lymphocytes were washed twice in complete RPMI and added to target cells at the
ratios stated. All assays were performed at 37'C for 3 h, after which supernatants were
removed by using a supernatant collection system (Skatron, Inc., Sterling, VA), and
counted for I min each in a gamma counter. Nonspecific "Cr release was consistently
<10% of the total for all target cells. Percent specific "Cr release (percent cytotoxicity)
' Abbreviation used in this paper:
￿
MNC, mononuclear cell.DALE AND BEACHEY
was calculated as follows: 100 x [(cpm experimental) - (nonspecific release)]/[(cpm total)
- (nonspecific release)].
Cytotoxicity inhibition experiments were performed by incubating the target and
effector cells in the presence of 10% rabbit antisera. Percent inhibition of cytotoxicity was
calculated based on controls incubated with normal rabbit serum (NRS). The antisera
were assayed for the presence of crossreactive antibodies against target cells by indirect
immunofluorescence by methods previously reported (11). Heart-crossreactive pep M5
antibodies were affinity purified from sarcolemmal membranes of human myocardium,
as described (11).
Generation of Cytotoxic T Cell Clones.
￿
MNC were isolated from normal human blood
and grown in the presence of 2 .5 Ag/ml pep M5 for 5 d (15). Cells were cloned by limiting
dilution in 96-well plates containing complete RPMI supplemented with 10% FCS, 2.5
Ecg/ml pep M5, 10 U/ml IL-2, and 105 irradiated (3,000 rad) MNC per well. Growing
cells were expanded in the presence of pep M5 and IL-2, and initially assayed for
cytotoxicity against Girardi heart cells and K562 cells. Stimulation indices were based on
[ H]thymidine incorporation in the presence and absence of pep M5. Cell surface phe-
notype was determined using the CD4 and CD8 monoclonal antibodies and analyzing on
a flow cytometer only viable cells, as determined by forward angle and _90 ° light scatter.
Results
Induction ofHuman CTL by Streptococcal M Proteins.
￿
Because previous studies
have shown that normal adult human lymphocytes proliferate in response to
purified pep M proteins, initial experiments were performed to detect cytotoxic
T lymphocytes that might be induced in vitro by the tissue-crossreactive M
proteins. Girardi heart cells were chosen as target cells because preliminary
studies have shown that heart-crossreactive antibodies evoked by pep M5 also
crossreacted with membrane antigens on the surface of these cultured cells.
Mononuclear cells cultured for 5 d in the presence of pep M5, M6, or M19
displayed significant cell-mediated cytotoxicity against Girardi heart cells at E/T
ratios as low as 5:1 (Table 1). Pep M24, which we have previously shown stimulates
lymphocyte blastogenesis (15), was not effective in inducing cytotoxic activity.
Control cells incubated in medium alone displayed little to no spontaneous
cytotoxic activity against the cultured heart cells.
The stimulation of CTL was dependent on the concentration of M protein,
TABLE I
In Vitro Stimulation ofHuman Cytotoxic T Lymphocytes against
Cultured Myocardial Cells with Purified Streptococcal M Proteins
Lymphocytes were cultured with 5 ug/ml of M protein or in medium
alone for 5 d. The cells were washed, counted, resuspended in fresh
medium, and added to "Cr-labeled heart cells at the ratios indicated.
After 3 h incubation, the amount of "Cr released was measured using a
Skatron harvesting device.
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TABLE 11
Target Cell Specificity ofHuman Cytotoxic Lymphocytes Evoked by
Type 5 Streptococcal MProtein
* E/T ratio 30:1 .
Target cells
Human myocardial cells (Girardi)
Human fibroblasts
Human livercells (Chang)
K562 cells
Mouse fibroblasts
Rat fibroblasts
Hamsterkidney cells (BHK)
FIGURE 1 .
￿
Dose-dependent pep M5 stimulation of cy-
totoxic lymphocy ytes against Girardi heart cells. Mono-
nuclear cells (10 cells/ml) were cultured for 5 d in the
presence of various concentrations of pep M5. Theeffec-
tor cells were washed and added to 'Cr-labeled target
cells at an E/T ratio of 30:1 . After incubating for 3 h,
the amount of "Cr released was assayed and percent
cytotoxicity was calculated as stated in Materials and
Methods.
FIGURE 2.
￿
Kinetics of pep M5 induction of cytotoxic
lymphocytes against Girardi heart cells. Mononuclear
cells were cultured with 10 Wg/ml pep M5 (O) or medium
alone (0) for the times specified, and then assayed for
cytotoxicity at an E/T cell ratio of 30:1 .
Percent specific "Cr release*
andcytotoxicity against heart cells reached a maximum when cells were cultured
with 5 wg/ml (Fig. 1). Studies of the kinetics of CTL induction showed that
cytotoxicity was maximal after 5 d exposure to pep M5 (Fig. 2), which parallels
previous data for peak blastogenic responses to Mprotein (15).
Target Cell Specificity of CTL Induced by MProtein.
￿
The target cell specificity
of M protein-stimulated cytotoxic lymphocytes was assayed using cell lines and
primary cultures of various human and animal tissues (Table II). In addition to
cytotoxic activity against Girardi heart cells, pep M5 also induced cytotoxicity
against primary cultures of human skin fibroblasts and Chang liver cells, a
continuous cell line. Spontaneous cytoxicity in control cultures was present only
against K562 cells, and pep M5 did not significantly enhance this activity. When
Control lym-
phocytes pulaMd lym-
phocytes phocytes
3.7 71 .5
7.2 69.7
2.6 79.8
55.3 62.6
0 14.5
5.0 19.5
0 5.7* E/T ratio30:1 .
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TABLE III
Inhibition ofCytotoxicity againstHumanHeartCells with Heart-crossreactive
pepM5 antibodies
Immunoflu-
￿
Percent specific "Cr
pep M5-stimulated human lymphocytes were incubated with primary cultures
of rat or mouse fibroblasts or a continuous cell line of hamster kidney cells,
minimalcytotoxicity was observed over that seenwithcontrol lymphocytes (Table
II). These data indicate that M protein stimulates cytotoxic cells with specificity
for multiple human target cells, and that the reactivity with animal target cells is
minimal to absent.
Inhibition of Cytotoxicity by Anti-pep M5 Heart-crossreactive Antiserum.
￿
To de-
termine whether pep M5-stimulated cytotoxic lymphocytes were recognizing M
protein crossreactive antigens on the surface of cultured heart cells, we per-
formed inhibition experiments with heart-crossreactive pep M5 rabbit antisera
(11, 12) (Table III). Preincubation of the target cells with rabbit antiserum
against pep M5 inhibited pep M5-stimulated cytotoxicity by 48%, as compared
with normal rabbit serum, whereas antiserum against human sarcolemmal mem-
branes had no inhibitory effect. This latter antiserum, however, crossreacted
strongly with the surface of Girardi heart cells, as determined by indirect
immunofluorescence tests, but did not react at all with pep M5, as determined
by ELISA (data not shown). In the second experiment (Table III), the anti-pep
M5 antiserum again partially inhibited cytotoxicity against heart cells. The pep
M5 antibodies that were affinity purified by eluting them from human sarcolem-
mal membranes also inhibited cytotoxicity, suggesting that antigens shared
between sarcolemmal membranes of human heart and Girardi heart cells may
be involved in the cytotoxic activity ofpep M5-stimulated human lymphocytes.
The pep M5 rabbit antisera did not crossreact by immunofluorescence tests with
fibroblasts or liver cells, and had no effect on cytotoxic activity against thesecells
(data not shown).
Characteristics of Effector Cells Stimulated by pep M5.
￿
To characterize the
populations ofcytotoxic effector cells induced by pep M5, we fractionated human
peripheral blood mononuclear cells according to cell surface markers by using a
fluorescence-activated cell sorter. The sorted cells were cultured with irradiated
orescence release:* Percentin-
Exp. Inhibitor reaction of
antisera
with Girardi
heart cells
Control
lymph-
cytes
pep M5-
Stimulated
lymphocytes
hibition of
cytotoxicity
1 Normal rabbit serum 0 18.1 78.3 -
Rabbit anti-pep M5 2+ 11 .3 40.3 48 .5
Rabbit anti-human sarcolemmal 3+ 15.3 82.1 0
membranes
2 Normal rabbit serum 0 6.4 32.8 -
Rabbit anti-pep M5 2+ 2.1 15.1 54.0
Anti-pep M5 eluted from hu- 2+ 2.8 19.0 42 .1
man sarcolemmal membranes1830
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TABLE IV
SurfacePhenotype ofHuman Cytotoxic TLymphocytes Induced by pep MS
feeder cells and M protein, and then each population was tested for cytotoxic
activity against heart and K562 cells (Table IV). As shown previously, unsorted
control cells demonstrated spontaneous cytotoxic activity against K562 cells,
which presumably represented NK activity (20) present in the mixed mononu-
clear cell preparation. pep M5 induced cytotoxicity against heart cells in the
unsorted populations. The CD3' lymphocytescultured in the absence ofpep M5
were devoid of cytotoxic activity against either target, indicating that cells with
spontaneous cytotoxic activity had been removed. However, pep M5 induced
cytotoxicity in the CD3' cells directed against both target cells. The majority of
thecytotoxic activity ofCD3' cells was recovered in CD8+lymphocytes; however,
CD4+ cells also showed some activity (Table IV). Although these results were
obtained with effector cells that were sorted before stimulation with M protein,
similar results were obtained when the effector populations were sorted after in
vitro activation (data not shown), suggesting that the cytotoxic cells were derived
from CD4' and CD8+ precursor lymphocytes that retained their phenotypic
expression ofthese antigens.
Because previous studies have shown that pep M proteins induce the produc-
tion of IFN-y but not IFN-a or -a from human mononuclear cells (21), and that
IFN may augment or induce (22) certain cytotoxic effector cells, we cultured
human lymphocytes in the presence ofneutralizing antibody against IFN-y and
tested the effector cells for cytotoxic activity (Table V). Anti-IFN-1' completely
abolished spontaneous cytotoxicity against K562 cells in unstimulated control
cultures. However, the antibody had no effect on the cytotoxicity oflymphocytes
cultured in the presence ofpep M5 (Table V).
To determine whether cytotoxic lymphocytes against heart cells were simply
the result ofactivation ofCD3' cells by IL-2 (23), we cultured mononuclear cells
in the presence of 10 U/ml purified IL-2 or 10 Ag/ml Con A, and assayed for
cytotoxic responses against heart cells, liver cells, and fibroblasts. None of the
target cells was lysed by the activated effector cells (data not shown), suggesting
that lymphocyte blastogenesis was necessary, but not sufficient, to induce cyto-
toxic effector cells with activity against the target cells tested.
Characteristics and Target Cell Specificity of M Protein-reactive Cytotoxic T Cell
Percent specific 5'Cr re-
Effector cells leasewith:
E/T ratio Cultureconditions
Girardi
heartcells K562
Unsorted 30:1 Medium control 7.4 48.0
pep M5 69.0 53.8
CD3' 30:1 Medium control 2.0 4.9
pep M5 45.2 37.1
CD4* 30:1 Medium control 0.5 0.5
pep M5 18.9 19.0
CD8* 15:1 Medium control 0 1.5
pep M5 37.4 46.9TABLE V
Effect ofAnti-IFN-y on Cytotoxic Lymphocytes Induced by pepM5
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TABLE VI
Target Cell Specific MProtein-responsive Human Cytotoxic TCell Clones
Clones.
￿
The data obtained with mixed populations of mononuclear cells or
CD3+ cells suggested that Mprotein inducedcytotoxic lymphocytes with multiple
target cell specificities (Table II). To assess whether individual effector cells
might have specificity for heart cells, as suggested by antibody inhibition studies,
we generated Mprotein-responsive T cell clones and tested each for cytotoxicity
against heart cells and K562 cells (Table VI). All ofthe Tcell clones underwent
blastogenesis in response to pep M5, as determined by [sH]thymidine incorpo-
ration in the presence and absence of pep M5. None of the cells responded to
streptokinase, whereasthedonor lymphocytesshowedbriskblastogenic responses
to this control antigen (data not shown). One ofthe four clones chosen for study
(T15) was cytotoxic against heart cells and not K562 cells. Two of the T cell
clones were cytotoxic against both target cells, and one was cytotoxic only against
K562 cells. Although the majority of the T cell clones were of the CD4+
phenotype, the heart cell-specific clone (T15) was CD8+. Taken together, these
data suggest that M protein induces cytotoxic T cells with multiple target cell
specificities; some of the clones have specific effector activity against heart cells
and not NK targets, whereas others are cytotoxic against more than one type of
target cell.
Discussion
In the present study, we have shown that purified pepsin-extracted fragments
of streptococcal M proteins induce CTL from normal individuals with activity
against several different target cells, including cultured myocardial cells. The
Clone Surface pheno-
type
Stimulation
index in re-
sponse to pep
M5
EST ratio
Percentspecific
with:
Girardi
heart
cells
"Cr release
K562 cells
T15 CD8+ 2.5 15:1 38 .1 2.5
111132 CD4+ 10.5 22:1 57 .1 47.9
T16 CD4+ 5.0 15:1 13.8 74.4
T20 CD4+ 2.2 10:1 0 59.0
Percentspecific
with:
"Cr release
Culturecondition Anti-IFN--y
Girardiheart K562 cells
Control - 5 48
+ 6 1
pep M5 - 22 41
+ 29 671832
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cytotoxic effector cells were derived from a CD3'' population that was devoid of
spontaneous cytotoxic activity against the NK-susceptible K562 cell line. Anti-
body inhibition experiments suggested that a portion of the cytotoxic cells
recognized cell surface antigens of Girardi heart cells that were M protein-
crossreactive, and initial experiments with M protein-reactive T cell clones
demonstrated cytotoxic activity against heart cells alone, K562 cells alone or
against both cell types.
The exact nature of the M protein-stimulated effector cells is not clear. The
target cell specificity of the cytotoxic cells induced in mixed populations by M
protein suggests that they are NK-like (24, 25), and the finding that lymphocytes
from all humans tested were cytotoxic against target cells from multiple origins
suggests that they are not MHC restricted. However, we showed that activation
alone, either by IL-2 or Con A, was not sufficient to induce cytotoxicity against
the target cells used in this study. The cytotoxicity against human but not
xenogeneic cells is similar to the activity of "anti-human effectors" reported by
Sugamura, et al. (26). Because the cytotoxic lymphocytes were induced in CD3+
cells that showed no spontaneous cytotoxicity against K562 cells, yet were not
MHC-restricted, we believe they represent non-MHC-restricted CTL, a term
recently proposed by Lanier, et al. (27). It is not yet known whether the M
protein-induced effector cells express the T cell receptor .r polypeptide, which
has recently been described on the surface of non-MHC-restricted CTL from
normal individuals (28).
The role of M protein-activated cytotoxic cells in the pathogenesis of strep-
tococcal infections or acute rheumatic fever is as yet unknown. The ability to
induce cytotoxic lymphocytes from all normal adults tested suggests that these
effectors may not be involved in the pathogenesis ofrheumatic fever, since only
a small percentage of the population appears to be genetically predisposed to
develop the disease. However, previous studies have shown that patients with
acute rheumatic carditis have circulating cytotoxic lymphocytes with activity
against myocardial cells (30), and guinea pigs immunized with group A strepto-
cocci develop cytotoxic lymphocytes against primary cultures ofheart cells (31).
Our data provide evidence that M proteins that contain tissue-crossreactive
epitopes induce cytotoxic effectors with broad target cell specificity, but a portion
ofthe cells appears tobespecific for culturedmyocardial cells. A detailed analysis
of the target cell specificity of cytotoxic lymphocytes from individuals with
rheumatic carditis or normal individuals that express the recently described
alloantigen 883 that predicts rheumatic fever susceptibility (32) may show a role
for tissue-specific cytotoxic cells induced by streptococcal M protein. The path-
ologic lesions of rheumatic carditis are most likely the result of complex inter-
actions between humoral and cellular autoimmune mechanisms. Of interest is
our finding that heart-crossreactive streptococcal antibodies inhibited cytotoxic-
ity against cultured heart cells but not other target cells, suggesting that under
some circumstances humoral autoimmune responses may be protective against
cell-mediated myocardial damage.
Perhaps relevant to these studies is a recent study (29) showing induction of
human cytotoxic lymphocytes by Salmonella species. The authors were unable
to correlate cytotoxicity with antibacterial activity. Whether or not M protein-DALE AND BEACHEY
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induced CTL are bactericidal against group A streptococci is currently under
investigation in our laboratory.
Our findings that M protein-induced CTL against several different target
cells may have direct bearing on previous studies of OK-432, a killed group A
streptococcal preparation that potentiates cytotoxic lymphocyte activity against
a variety oftumor cells in humans and animals (33-35). Although OK-432 has
been shown to augment NKactivity (34), there isalso evidence that the substance
induces NK-like cells with multiple target cell specificities (33). Previous studies
have shown that at least a portion of the immunopotentiating activity resides in
the M protein fraction ofstreptococcal extracts (35).
In summary, we have shown that purified M proteins from three different
serotypes ofgroup Astreptococci evoke cytotoxic Tlymphocytes against several
different cultured target cells; some of the cytotoxic cells appear to have speci-
ficity for myocardial cells. The exact role ofMprotein-stimulated cell-mediated
cytotoxicity in the pathogenesis of rheumatic carditis is not yet clear; however,
further studiesto define the target cell specificity and mechanisms ofcytotoxicity
using lymphocytes from patients with acute rheumatic fever may provide more
definitive answers.
Summary
Purified group A streptococcal M proteins were used to stimulate peripheral
blood lymphocytes from normal adult volunteers. The activated lymphocytes
were cytotoxicagainstculturedhuman heartcells, as wellaslivercells, fibroblasts,
and K562 cells, but showed only minimal cytotoxicity against several animal cell
types. The cytotoxic activity evoked by type 5 M protein was dose and time
dependent. Rabbit antisera against pep M5 that contained heart-crossreactive
antibodies partially inhibited cytotoxicity against heart cells, but had no effect
on other target cells, suggesting that a fraction of the effector lymphocytes may
be recognizing Mprotein-crossreactive cell surface antigens. All ofthe cytotoxic
activity was recovered from a CD3' population of lymphocytes obtained from a
fluorescence-activated cell sorter, and CD4+ and CD8+ cells were also cytotoxic.
M protein-responsive T cell clones were generated that showed specificity for
heart and K562 cells, in addition to clones that were cytotoxic against both cell
lines. Ourdatashow that streptococcal Mprotein evokes cytotoxic T lymphocytes
against multiple human but not animal target cells. Some of the effector cells
may be specific for cultured myocardial cells, but their role in the pathogenesis
of rheumatic carditis will require further studies of lymphocytes from patients
with acute rheumatic fever and carditis.
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